Loading company details...
Latest Form 4 (Nov 5, 2026): George Magrath (Chief Executive Officer): Sale of 28,258 shares, $110.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | George Magrath, Chief Executive Officer | Sale | 28,258 | $110.2K |
| Oct 27, 2026 | Joseph K. Schachle, Chief Operating Officer | Sale | 4,767 | $17.0K |
| Oct 27, 2026 | Benjamin R. Yerxa, President | Sale | 7,669 | $27.2K |
| Oct 27, 2026 | Robert E. Gagnon, Chief Financial Officer | Sale | 14,000 | $49.6K |
| Oct 27, 2026 | George Magrath, Chief Executive Officer | Sale | 9,591 | $34.4K |
| Oct 2, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Sale | 556,000 | $2.76M |
| Sep 11, 2026 | George Magrath, Chief Executive Officer | Exercise/Conversion | 392,157 | $451.0K |
| Sep 8, 2026 | Cam Gallagher | Exercise/Conversion | 784,314 | $902.0K |
| Sep 8, 2026 | Robert E. Gagnon, Chief Financial Officer | Sale | 28,000 | $127.2K |
| Jul 27, 2026 | Benjamin R. Yerxa, President | Sale | 7,429 | $22.1K |